769
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Peri-tumoral leakage during intra-tumoral convection-enhanced delivery has implications for efficacy of peri-tumoral infusion before removal of tumor

, , , , , , , & show all
Pages 771-776 | Received 16 Feb 2014, Accepted 10 Apr 2014, Published online: 28 May 2014

References

  • Baxter LT, Jain RK. (1989). Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. Microvasc Res 37:77–104
  • Bidros DS, Liu JK, Vogelbaum MA (2010). Future of convection-enhanced delivery in the treatment of brain tumors. Future Oncol 6:117–25
  • Bobo RH, Laske DW, Akbasak A, et al. (1994). Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA 91:2076–80
  • Boucher Y, Baxter LT, Jain RK. (1990). Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res 50:4478–84
  • Boucher Y, Jain RK. (1992). Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res 52:5110–14
  • Boucher Y, Salehi H, Witwer B, et al. (1997) Interstitial fluid pressure in intracranial tumours in patients and in rodents. Br J Cancer 75:829–36
  • Brandes AA. (2003). State-of-the-art treatment of high-grade brain tumors. Semin Oncol 30:4–9
  • DeAngelis LM. (2003). Benefits of adjuvant chemotherapy in high-grade gliomas. Semin Oncol 30:15–18
  • Groothuis DR. (2000). The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery. Neuro-oncol 2:45–59
  • Jemal A, Murray T, Samuels A, et al. (2003). Cancer statistics, 2003. CA Cancer J Clin 53:5–26
  • Kikuchi T, Saito R, Sugiyama S, et al. (2008). Convection-enhanced delivery of polyethylene glycol-coated liposomal doxorubicin: characterization and efficacy in rat intracranial glioma models. J Neurosurg 109:867–73
  • Kunwar S. (2003). Convection enhanced delivery of IL13-PE38QQR for treatment of recurrent malignant glioma: presentation of interim findings from ongoing phase 1 studies. Acta Neurochir Suppl 88:105–11
  • Kunwar S, Prados MD, Chang SM, et al. (2007) Cintredekin Besudotox Intraparenchymal Study Group. Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol 25:837–44
  • Navalitloha Y, Schwartz ES, Groothuis EN, et al. (2006). Therapeutic implications of tumor interstitial fluid pressure in subcutaneous RG-2 tumors. Neuro-oncol 8:227–33
  • Rosenberg GA, Kyner WT, Estrada E (1980). Bulk flow of brain interstitial fluid under normal and hyperosmolar conditions. Am J Physiol 238:F42–9
  • Saito R, Bringas JR, McKnight TR, et al. (2004) Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Cancer Res 64:2572–9
  • Sampson JH, Archer G, Pedain C, et al. (2010). Poor drug distribution as a possible explanation for the results of the PRECISE trial. J Neurosurg 113:301–9
  • Stupp R, Mason WP, van den Bent MJ, et al. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–96
  • Sugiyama S, Yamashita Y, Kikuchi T, et al. (2007). Safety and efficacy of convection-enhanced delivery of ACNU, a hydrophilic nitrosourea, in intracranial brain tumor models. J Neurooncol 82:41–7
  • Vogelbaum MA, Sampson JH, Kunwar S, et al. (2007). Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results. Neurosurgery 61:1031–7
  • Walter KA, Tamargo RJ, Olivi A, et al. (1995). Intra-tumoral chemotherapy. Neurosurgery 37:1128–45
  • Watanabe M, Tanaka R, Takeda N. (1992). Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 34:463–9
  • Yang W, Barth RF, Huo T, et al. (2014). Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors. Radiat Oncol 9:25

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.